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Background: Dehydroepiandrosterone (DHEA) is precursor of sex steroid hormone. We demonstrated that acute
DHEA injection to type 1 diabetes model rats induced improvement of hyperglycemia. However, the effect of the
combination of DHEA administration and exercise training on insulin resistance is still unclear. This study was
undertaken to determine whether 6-weeks of DHEA administration and/or exercise training improve insulin
resistance in obese male rats.
Methods: After 14 weeks of a high-sucrose diet, obese male Wistar rats were assigned randomly to one of four
groups: control, DHEA administration, exercise training, and a combination of DHEA administration and exercise
training (n= 10 each group).
Results: After 6-weeks of DHEA administration and/or exercise training, rats in the combination group weighed
significantly less and had lower serum insulin levels than rats in the other groups. Moreover, the rats treated with
DHEA alone or DHEA and exercise had significantly lower fasting glucose levels (combination, 84 ± 6.5 mg/dL;
DHEA, 102 ± 9.5 mg/dL; control, 148 ± 10.5 mg/dL). In addition, insulin sensitivity check index showed significant
improvements in the combination group (combination, 0.347 ± 0.11; exercise, 0.337 ± 0.16%; DHEA, 0.331 ± 0.14;
control, 0.308 ± 0.12). Muscular DHEA and 5α-dihydrotestosterone (DHT) concentrations were significantly higher in
the combination group, and closely correlated with the quantitative insulin-sensitivity check index (DHEA: r= 0.71,
p< 0.01; DHT: r= 0.69, p< 0.01).
Conclusion: These results showed that a combination of DHEA administration and exercise training effectively
improved fasting blood glucose and insulin levels, and insulin sensitivity, which may reflect increased muscular
DHEA and DHT concentrations.
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Obesity is one of the risk factors for type 2 diabetes, cardio-
vascular diseases, hypertension, and dyslipidemia. The
obesity and type 2 diabetes patients show lower concentra-
tions of dehydroepiandrosterone (DHEA) and other sex
steroid hormone [1-3]. Decreased DHEA levels in obese
patients or those with type 2 diabetes are related to insulin-
induced inhibition of enzyme activity for adrenal androgen
synthesis [4]. However, DHEA administration and exercise
leads to increases in muscular steroidogenesis-related
enzymes and concomitant increases in plasma and muscu-
lar DHEA and 5α-dihydrotestosterone (DHT) levels in rats* Correspondence: safujita@fc.ritsumei.ac.jp
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reproduction in any medium, provided the or[5-7]. Moreover, several reports demonstrated that short-
term (2 weeks) DHEA administration induced an acute de-
crease in blood glucose levels in mice [8,9], reduced serum
insulin levels in older rats [2,10,11], and enhanced the activ-
ities of enzyme related to hepatic glucose metabolismin
diet-induced or Zucker obese rats [12,13]. Recently, we
have reported that acute DHEA injections improved hyper-
glycemia in streptozotocin (STZ)-induced diabetic rats
[7]. In addition, Han and colleagues [14] demon-
strated an enhanced insulin sensitivity in response to
2 weeks of wheel-running exercise and DHEA ad-
ministration in 25-month-old rats, although additive
effects of the treatments were not apparent.
DHEA and its sulfate derivate (DHEA-S) are precursors
of sex steroid hormones, that circulate in blood before. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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duced by adrenal, but several studies demonstrated that
brain, liver, bone and any other tissues can also produce
DHEA in both human and rodents [15-17]. Recently, we
demonstrated that skeletal muscle can locally synthesize
DHT from DHEA and testosterone [18]. According to our
previous studies, acute aerobic exercise enhances the local
bioactive androgen metabolism, and increased DHEA and
DHT levels in skeletal muscle (5, 6). It is still unclear
whether the combination of chronic DHEA administration
and aerobic exercise training increases muscular level of
DHEA and DHT, and it induces the improvement of insulin
resistance more effectively in obesity.
We hypothesized that, compared with either DHEA ad-
ministration or exercise training treatment alone, 6-weeks
of DHEA administration combined with exercise training
in obese rats would produce larger effects on steroidogen-
esis from DHEA to DHT in skeletal muscle and improve-
ments in insulin sensitivity. To test this hypothesis, we
investigated fasting blood glucose, insulin levels, the quan-
titative insulin-sensitivity check index (QUICKI) as an
index of insulin sensitivity after 6-weeks of DHEA admin-
istration, exercise training, or both in rats with diet-
induced obesity.
Methods
Ethical approval for this study was obtained from the
Committee on Animal Care at the University of Tsukuba.
Male Wistar rats (220–250 g, 10 weeks old; Charles River
Japan, Kanagawa, Japan) were cared for according to The
Guiding Principles for the Care and Use of Animals based
on the Declaration of Helsinki. The Wistar rats were
housed individually in an animal facility under controlled
conditions (12:12-h light–dark cycle). The rats were
allowed water ad libitum and placed on a purified high-
sucrose diet (68% of kcal from sucrose, 20% from protein,
and 12% from fat) for 14 weeks, according to a previous
study with minor modifications [19]. After 14 weeks of
the high-sucrose diet, the animals were randomly assigned
to one of four groups: sedentary rats administered sesame
oil (control group, n=10), obese rats treated with DHEA
(DHEA group, n=10), obese rats subjected to exercise
training (exercise group, n= 10), and obese rats treated
with DHEA and subjected to exercise training (combin-
ation group, n=10). DHEA was obtained fromWako Pure
Chemical Industries (Osaka, Japan). All animals continued
on the high-sucrose diet during the 6-week experimental
period. In the DHEA and combination groups, DHEA
(1 mg/kg body weight) dissolved in sesame oil was admi-
nistered orally every day for 6 weeks. In the control group,
the same amount of vehicle (sesame oil) was administered
orally every day. Body weight and dietary intake were
measured every week during the experiment. Post-
training experiments in trained rats were performed 48 hafter the last round of exercise training. After all other
measurements were obtained the soleus and gastrocne-
mius muscles were quickly removed, weighed, rinsed in
ice-cold saline, and frozen in liquid nitrogen.
Exercise protocol
The obese exercise training group was trained on a rodent
treadmill (KN-73, Natsume Seisakusyo, Tokyo, Japan) at
about 10–25 m/min over a period of 3 days for accus-
tomed to the treadmill. The rats then ran on the treadmill
for 1 h at 25 m/min without incline 5 days/week for
6 weeks. The intensity, duration and time of the exercise
was kept constant during the rest of the training period.
Protein assay and muscle concentrations of DHEA
and DHT
Muscle specimens were homogenized in 20 mM Tris–HCl
(pH 7.8), 300 mM NaCl, 2 mM ethylenediaminetetraacetic
acid (EDTA), 2 mM dithiothreitol (DTT), 2% noni-
dent P-40, 0.2% sodium lauryl sulphate (SDS), 0.2%
sodium deoxycholate, 0.5 mM phenylmethylsulfonyl
fluoride, 60μg/ml aprotinin, and 1 μg/ml leupeptin.
Homogenates were rotated slowly for 30 min at 4°C and
then centrifuged at 12,000× g for 15 min at 4°C. The pro-
tein concentration of the resulting supernatant was deter-
mined. For the determination of DHEA and DHT levels,
muscle samples were diluted by 200 times with each assay
buffer. The levels of DHEA and DHT in skeletal muscle
extracts were determined using Enzyme-Linked Immuno
Sorbent Assay (ELISA) kit (Assay Designs, Ann Arbor, MI,
IBL Hamburg, Germany). The techniques and materials
used in these analyses followed the manufacturer’s protocol.
The immobilized polyclonal antibodies were raised against
DHEA and DHT, whereas the secondary horseradish-
peroxidase-coupled antibodies were monoclonal. Optical
density at 450 nm was measured on a microplate reader
(BioLumin 960; Molecular Dynamics, Tokyo, Japan). All
samples were assayed in duplicate.
Glucose and insulin concentrations
Serum insulin concentrations were measured using an
ELISA kit (Shibayagi Co, Gunma, Japan), according to the
manufacturer’s protocol. All samples were assayed in du-
plicate. Optical density at 450 nm was qualified using a
microplate reader (BioLumin 960; Molecular Dynamics,
Tokyo, Japan). Fasting glucose was assessed from the tail
vein before and after the treatment period under overnight
fasting condition. Glucose concentrations were assessed
three times from the tail vein using a blood glucose meter
(Ascensia, Bayer HealthCare, Tokyo, Japan).
Insulin sensitivity
QUICKI was calculated according to the previous study
from fasting glucose and insulin vaues [20-22]. QUICKI=
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and G0 is fasting glucose (mg/dl).
Statistical analysis
All values are expressed as means ± SE. Statistical eva-
luations were performed using repeated measures two-
way ANOVA (time × group) for weight changes. A
post-hoc comparison test was used to correct for multiple
comparisons (Bonferroni test) when analyses revealed sig-
nificant differences. For ANOVA, P< 0.01 was considered
significant. Relationships between sex steroid hormone
concentrations and the quantitative insulin-sensitivity check



























Figure 1 Body weight before and after dehydroepiandrosterone
(DHEA) treatment and exercise training in obese rats fed a
high-sucrose diet. Diamonds: Control group. Circles:DHEA treatment
group. Squares: Exercise training group. Triangles: Combination
group Data are means ± SE from 10 animals. Pre: before DHEA
treatment and/or exercise training. The x axis represents the weeks
of DHEA treatment and/or exercise training. * p< 0.01 compared
with the control group. †p< 0.01 compared with the DHEA group. {
p< 0.01 compared with the exercise training group.Results
Body weight
Body weight before the treatment periods did not differ
among the groups. After 6 weeks of DHEA administration
and/or exercise training, body weight was significantly
(p< 0.01) lower in the combination group than in the
control group. After 5 weeks, body weight was signifi-
cantly (p< 0.01) lower in the combination group than in
the DHEA group or the exercise group (Figure 1). Final
body weights in the DHEA and exercise groups were sig-
nificantly lower than in the control group. Moreover, the
combination group showed a significantly lower body
weight than the other groups (Figure 1).
Dietary intake, muscle weight and epididymal fat weight
Exercise training and DHEA administration did not de-
crease food intake of the rats. Average food intake during
the 6 weeks was 19.74±0.62 g/day in the control group,
19.64±0.37 g/day in the DHEA group, 19.61±0.43 g/day
in the exercise group, and 19.59±0.53 g/day in the combin-
ation group. No significant difference in the food intake
was found among groups during the treatment period
(Table 1).
Table 1 shows the weights of the soleus and gastrocne-
mius muscles after the treatment period. Marked
increases in the weight of the soleus and gastrocnemius
muscles were observed in the exercise and combination
groups compared with the control and DHEA groups.
The soleus and gastrocnemius muscles weighed signifi-
cantly more in the DHEA group than in the control
group (p< 0.01, Table 1). Epididymal fat weight was sig-
nificantly decreased in combination group compared to
control and exercise group (p< 0.01, Table 1).
Fasting glucose levels, serum insulin levels, and QUICKI
The fasting glucose levels were not significantly different
among groups before the treatment periods (Table 1).
After 6 weeks of DHEA administration and/or exercisetraining, fasting glucose levels were significantly lower in
the DHEA, exercise, and combination groups than in
the control group. Moreover, fasting glucose levels
in the combination group were significantly lower than
in the DHEA group (Table 1).
After 6 weeks of DHEA administration and/or exer-
cise training, the serum insulin levels were significantly
lower in the DHEA, exercise, and combination groups
than in the control group. Serum insulin levels were also
significantly lower in the combination group than in the
other groups (Figure 2A). Similarly, QUICKI were sig-
nificantly higher in the DHEA, exercise, and the com-
bination groups than in the control group (p< 0.01.
Figure 2B). Of particular interest, the QUICKI were sig-
nificantly higher in the combination group than in the
other groups (p< 0.01). No significant correlation be-
tween body weight and fasting glucose, or body weight
and QUICKI was found in the present study.Intramuscular DHEA and DHT concentrations
Intramuscular DHEA and DHT concentrations were sig-
nificantly greater in the DHEA, exercise, and combin-
ation groups than in the control group. The DHEA and
DHT concentrations were also significantly greater in
the combination group than in either the DHEA or exer-
cise group (Figures 3A and 3B). Of note, intramuscular
DHEA and DHT concentrations significantly correlated
Table 1 Animal characteristics
Sedentary(n = 10) DHEA(n= 10) Training(n= 10) Training-DHEA(n = 10)
Muscle weight (g/body weight)
Soleus 0.32 ± 0.02 0.48 ± 0.04 * 0.56 ± 0.03 *† 0.57 ± 0.04 *†
Gastrocnemius 3.63 ± 0.6 4.31 ± 0.3 * 4.66 ± 0.3 *† 4.73 ± 0.3 *†
Epididymal fat (g) 38.2 ± 4.8 27.4 ± 3.6 * 33.8 ± 2.8 23.7 ± 4.1 *{
Dietary intake(g/day) 19.74 ± 0.62 19.64 ± 0.37 19.61 ± 0.43 19.59 ± 0.53
Pre-fasting glucose(mg/dl) 154 ± 11.5 159± 10.2 162 ± 8.7 158 ± 9.8
Post-fasting glucose(mg/dl) 148 ± 10.5 102± 9.5 * 92 ± 7.8 * 84 ± 6.5 *†
DHEA:dehydroepiandrosterone.
Pre-fasting glucose: fasting glucose level before DHEA administration and/or exercise training.
Post-fasting glucose: fasting glucose level after DHEA administration and/or exercise training.
Data are means ± SE.
* P< 0,05, vs Sedentary control group.
†P< 0.05, vs DHEA treatment group.
{P< 0.05, vs Training group.
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p< 0.001. Figure 4).
Discussion
Results from this study demonstrated that 6-weeks of
DHEA treatment with exercise training induced larger
decreases in fasting glucose levels than results observed
for DHEA administration alone. The combined interven-
tions were more beneficial for insulin resistance and
body weight than either DHEA administration or exer-
cise training alone. These effects in the combination
group may have reflected significant increases in muscu-
lar DHEA and DHT levels, which closely correlated with
QUICKI.
In the present study, both exercise training and DHEA
administration significantly increased muscular concen-
trations of DHEA and DHT, and these increases were
even more pronounced when these treatment modalities
were combined. In fact, muscular DHEA and DHT con-
centrations significantly correlated with QUICKI in this
study. Recently, a single DHEA injection in rats with
STZ-induced diabetes was shown to reverse impaired
GLUT-4-related signaling in muscle, such as Akt/PKCζ/λ
activity and GLUT-4 translocation [7]. Additionally, short-
term exercise training is known to improve blood glucose
levels and accelerate muscular glucose uptake and
utilization [23]. Therefore, the combination of DHEA ad-
ministration and exercise training may additively or syner-
gistically improve blood glucose levels and activate the
glucose uptake in skeletal muscle. According to Han et al.
[14], plasma insulin levels decreased and the glucose infu-
sion rate was increased by DHEA treatment and voluntary
running-wheel training in 25-month-old rats. Additive
effects were not observed in the combination group,
however. In the present study, a 6-week regimen of DHEA
administration and exercise training resulted in larger
improvements in hyperglycemia and insulin resistance inthe obese rats. Consequently, a longer treatment period,
such as the 6-week regimen used in this study, may be
required to obtain additive benefits for improvement of in-
sulin sensitivity in diet-induced obese rats.
Although DHEA administration and exercise training
each produced beneficial effects, 6-weeks of combination
treatment were more effective for obesity. The precise
mechanisms that reduced abdominal fat weight in the com-
bination group remain unclear, yet we can propose several
plausible hypotheses. 2 weeks of DHEA administration has
been shown to activate fatty acid metabolism-related
enzymes, such as long-chain fatty acyl-coenzyme A syn-
thase, and to increase free CoA levels in liver [12,13]. In
addition, exercise training is known to reduce adipogenesis
via upregulation of fatty acid metabolism and increased en-
ergy expenditure [24]. Therefore, 6-weeks of combination
treatment may have promoted additive reductions in ab-
dominal fat volume.
Patients with metabolic syndrome have lower DHEA and
DHEA-S levels [25]. We recently demonstrated that DHEA
enhanced GLUT-4-relatedsignaling in cultured skeletal
muscle cells [18]. Furthermore, rats with STZ-induced dia-
betes had lower muscle DHEA concentrations, and acute
DHEA injections improved GLUT-4-relatedsignaling with
increased muscular DHEA and DHT levels. Therefore,
muscular DHEA and DHT levels appear to be related to
blood glucose levels in obesity and type 2 diabetes. The
present study showed that DHEA administration, exercise
training, and combination of the two modalities signifi-
cantly increased basal muscular DHEA and DHT levels.
Moreover, brief exercise significantly increases muscular
levels of DHEA and steroidogenesis-related enzymes [5,6].
Exercise training is beneficial for patients with insulin re-
sistance and hyperinsulinemia [26,27]. Although exercise
training has been shown to improve insulin resistance and
glucose metabolism in obese patients with type 2 diabetes,






































Figure 2 Effects of DHEA treatment and/or exercise training on
serum insulin levels (A) and the QUICKI (B). Data are the
means ± SE from 10 animals. * p< 0.01 compared with the control
group. †p< 0.01 compared with the DHEA group. { p< 0.01







































































Figure 3 Effects of DHEA treatment and/or exercise training on
muscle DHEA and 5α-dihydrotestosterone (DHT)
concentrations. Data are means ± SE from 10 animals. *p< 0.01
compared with the control group. †p< 0.01 compared with the
DHEA group. { p< 0.01 compared with the exercise training group.
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than either therapy alone. Increasing basal muscular DHEA
and DHT levels with DHEA and regular exercise may pro-
vide additive benefits for reducing abdominal fat weight
and improving insulin resistance in obesity. However, the
present study was conducted with relatively small number
of experiments; therefore, further studies are warranted to
confirm the current findings and to clarify the molecular
mechanisms for combined benefits of DHEA and exercise
training.Although this combined treatment modalities may pro-
vide a new therapeutic avenue for obesity and insulin resist-
ance related to obesity, previous studies have reported
some mixed results. While one study indicated that DHEA
administration improved insulin sensitivity in elderly people
[28,29], others demonstrated no improvement in insulin
sensitivity or body composition [30]. Therefore, further
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Figure 4 Correlations between muscular DHEA and the QUICKI (A) and muscular DHT and the QUICKI (B) in combination treatment groups.
Sato et al. Nutrition & Metabolism 2012, 9:47 Page 6 of 7
http://www.nutritionandmetabolism.com/content/9/1/47supplementation not only in healthy adults but also in
obese or diabetic patients.
In conclusion, the results from this study demonstrated
that 6-weeks of DHEA administration combined with exer-
cise training produced larger benefits for insulin sensitivity,
body weight, and abdominal fat compared with DHEA ad-
ministration or exercise training alone.
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